Senior Research Officer
Genetics
Murdoch Childrens Research Institute
Australia
The primary focus of her research program is to develop cell and gene therapies and identify therapeutic targets for Friedreich ataxia. She has received Young Investigator Awards from the Friedreich Ataxia Research Alliance, USA and the Australasian Gene and Cell Therapy Society. She has also received travel awards to present her research internationally. With experience on multiple institute, government and educational committees, Dr Evans-Galea regularly peer reviews for international journals and funding bodies, and currently serves on two editorial boards. She also serves on the Immune Responses Committee of the American Society for Gene and Cell Therapy, the executive committee of the Australasian Gene and Cell Therapy Society and the executive of the Australian Science and Innovation Forum, a partner of the Australian Academy of Technological Sciences and Engineering.
gene therapy